-
Mashup Score: 42020 ASH Meeting on Hematologic Malignancies - 4 year(s) ago
The ASH Meeting on Hematologic Malignancies features the top experts in the field, comprehensive clinical content, and the opportunity to interact with colleagues. The 2020 meeting webcasts are an opportunity to hear experts present cutting-edge scientific data, out-of-the-box treatment approaches, and challenging patient care cases during topic-based panel discussions. The program content is…
Source: ashondemand.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Meetings - 4 year(s) ago
Meeting Type: The ASH Meeting on Hematologic Malignancies features the top experts in the field, comprehensive clinical content, and the opportunity to interact with colleagues in an…
Source: ashondemand.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1ASH Meeting on Hematologic Malignancies: A Virtual Experience - 4 year(s) ago
The ASH Meeting on Hematologic Malignancies features the top experts in–the field, comprehensive clinical content, and the opportunity to interact with colleagues – all through a virtual experience.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3ASH Meeting on Hematologic Malignancies: A Virtual Experience - 4 year(s) ago
The ASH Meeting on Hematologic Malignancies features the top experts in–the field, comprehensive clinical content, and the opportunity to interact with colleagues – all through a virtual experience.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1ASH Meeting on Hematologic Malignancies: A Virtual Experience - 4 year(s) ago
The ASH Meeting on Hematologic Malignancies features the top experts in–the field, comprehensive clinical content, and the opportunity to interact with colleagues – all through a virtual experience.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0ASH Meeting on Hematologic Malignancies: A Virtual Experience - 4 year(s) ago
The ASH Meeting on Hematologic Malignancies features the top experts in–the field, comprehensive clinical content, and the opportunity to interact with colleagues – all through a virtual experience.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5ASH Meeting on Hematologic Malignancies: A Virtual Experience - 4 year(s) ago
The ASH Meeting on Hematologic Malignancies features the top experts in–the field, comprehensive clinical content, and the opportunity to interact with colleagues – all through a virtual experience.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2ASH Meeting on Hematologic Malignancies: A Virtual Experience - 4 year(s) ago
The ASH Meeting on Hematologic Malignancies features the top experts in–the field, comprehensive clinical content, and the opportunity to interact with colleagues – all through a virtual experience.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ASHMHM20 Attendees! Don’t forgot to attend tomorrow's LIVE sessions happening between 11:45 AM & 5:00 PM EST. If you haven't registered yet, tomorrow is the last day to register & gain access to the content until October 12: https://t.co/lJthuCRU0o #leusm #lymsm #mdssm #mpssm https://t.co/JavDtncxA6
-
-
Mashup Score: 7Which Drug Therapy for CLL, Time-Limited or Continuous? - 4 year(s) ago
With several different options now available for drug treatment of chronic lymphocytic leukemia (CLL), discussions have become lengthy as the choice needs to be individualized, one expert says.
Source: MedscapeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0ASH Meeting on Hematologic Malignancies: A Virtual Experience - 4 year(s) ago
The ASH Meeting on Hematologic Malignancies features the top experts in–the field, comprehensive clinical content, and the opportunity to interact with colleagues – all through a virtual experience.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
RT @ASH_hematology: You can still access great content like this from #ASHMHM20! View available webcasts here: https://t.co/bg18bDCv5r #l…